Mark Saunders
Principal
New York

Impact fact
Mark has spent 10 years leading relationships with top pharma clients, most recently completing five years as a member or chair of ZS’s client service council.
Impact fact
Mark has spent 10 years leading relationships with top pharma clients, most recently completing five years as a member or chair of ZS’s client service council.
Role
Role
Mark is the lead partner for ZS’s engagement with a global top 10 pharma organization. As ZS’s lead for HIV thought leadership, he works to understand the current and future landscape and provide strategic insight and innovative ideas to our clients. Mark is also a leader in customer experience optimization and organizational capability building and is the owner of several ZS products in this space.
Expertise
Expertise
Mark has built strong relationships across client organizations, such as R&D, supply, medical and commercial. He has a broad industry perspective that spans all key ZS client pharma organizations.
He has deep therapy area expertise in HIV, rare diseases, vaccines and respiratory conditions and a breadth of experience across commercial, pipeline and clinical strategy, customer experience optimization, advanced analytics, customer insight and launch planning.
He is also passionate about helping young leadership identify and reach their potential as the current lead of the ZS program for new client service lead partners and for client relationship-building. In these roles, he serves as a new manager training lead and a professional development coach for future leaders in the firm. He believes in ensuring inclusive development opportunities for all and is the EU ally partner for the Women@ZS program.
Prior experience
Prior experience
Prior to joining ZS, Mark worked as part of a global think tank for the Science and Technology Brief. He also spent time as an academic researcher and teacher in higher education.
Education
Education
Mark holds a master’s in chemistry and a Ph.D. in chemical physics, both from Oxford University.